The treatment with fremanezumab becomes the first approved therapy to demonstrate efficacy in children and adolescents, a key stage of life as it is one of the most disabling and concentrates the peak...
Read moreSant Joan de Déu coordinates the European project AriChall, an international initiative that promotes a new clinical trial with the aim of identifying a treatment for children with acute lymphoblasti...
Read moreHaving alternatives with fewer drugs may reduce cumulative lifetime exposure to medication and offers new options in cases of resistance or intolerance to integrase inhibitors
Read moreRegulatory guidance recognizes that advanced therapy medicinal products differ fundamentally from conventional drugs because variability may arise from living systems, manufacturing environments, and ...
Read moreInvestment in R&D reached €12.6 million, representing an increase of 50% (€4.2 million) compared to the €8.4 million invested in the previous financial year.
Read moreThe AI revolution in Pharmaceutical R&D is transitioning from experimental curiosity to operational necessity. This transformation is supported by quantifiable operational improvements: AI-enabled dis...
Read moreMonQAI is a digital platform aimed at hospitals, drug research ethics committees and clinical trial sponsors that uses generative artificial intelligence (AI) to streamline and optimize the clinical s...
Read moreCompared with other antiretroviral treatments, dolutegravir leads to a more balanced microbiome, similar to that of people without HIV, with lower inflammation and reduced immune system activation
Read moreOn World Obesity Day, scientists from the Institute of Nutrition and Health at the University of Navarra present research aimed at advancing toward more personalized treatment on a portal
Read moreMaking reimbursement of expenses or compensation for loss of productivity reach the patient in clinical trials can sometimes pose a major obstacle to the daytoday operations of hospital sites. At the ...
Read moreEl Dr. Jordi Antón, jefe del Servicio de Reumatología Pediátrica de Sant Joan de Déu, explica los avances en la aplicación de las terapias CAR-T en las enfermedades autoinmunes sistémicas pediá...
Read morePublished today in The Lancet, these positive results could lead to the regulatory approval of pimicotinib as an effective and well-tolerated therapeutic option, representing an important step forward...
Read more